Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ETHAN: A Phase II Study Comparing Different Endocrine THerapies for mAle Breast caNcer

NCT05501704 is registered in ClinicalTrials.gov with Jose Pablo Leone as lead sponsor.

NCT NCT05501704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05501704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ETHAN: A Phase II Study Comparing Different Endocrine THerapies for mAle Breast caNcer
Lead sponsor
Jose Pablo Leone
Phase
Phase 2
Overall status
Recruiting
Start date
October 11, 2023
Completion date
April 1, 2036
Enrollment
60 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor negative breast carcinoma, hormone receptor-positive breast cancer, male breast cancer